This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Gastrointestinal (GI) diseases that affect various portions of the GI tract as well as digestive organs such as the liver, pancreas, and gallbladder. Some disorders that affect other areas of the gastrointestinal tract can show up in the mouth, either alone or in combination. GI diseases affect millions of people around the world and are a leading cause of morbidity and mortality. Diarrhoea, abdominal pain, abdominal distention, gastrointestinal haemorrhage, intestinal obstruction, malabsorption, or malnutrition are some of the most prevalent symptoms of gastrointestinal diseases. Irritable bowel syndrome affects 20% of the population, while dyspepsia affects 40%. Less than one third of patients seek help and support from a general practitioner for these issues, and anxiety of serious disease and cancer is just as crucial as symptom severity in determining whether or not to seek help.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States